Frankfurt - Delayed Quote EUR

Vivoryon Therapeutics N.V. (05Y.F)

Compare
2.0200
+0.0300
+(1.51%)
At close: January 10 at 10:17:28 AM GMT+1
All numbers in thousands
Breakdown
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Assets
30,829.0000
31,378.0000
24,520.0000
29,751.0000
Total Liabilities Net Minority Interest
4,547.0000
4,872.0000
7,963.0000
3,530.0000
Total Equity Gross Minority Interest
26,282.0000
26,506.0000
16,557.0000
26,221.0000
Total Capitalization
26,282.0000
26,506.0000
16,557.0000
26,221.0000
Common Stock Equity
26,282.0000
26,506.0000
16,557.0000
26,221.0000
Capital Lease Obligations
38.0000
132.0000
224.0000
314.0000
Net Tangible Assets
25,341.0000
26,012.0000
16,024.0000
25,656.0000
Working Capital
26,630.0000
27,429.0000
15,178.0000
27,468.0000
Invested Capital
26,282.0000
26,506.0000
16,557.0000
26,221.0000
Tangible Book Value
25,341.0000
26,012.0000
16,024.0000
25,656.0000
Total Debt
38.0000
132.0000
224.0000
314.0000
Share Issued
26,066.8080
24,105.2780
20,050.4820
19,975.4820
Ordinary Shares Number
26,066.8080
24,105.2780
20,050.4820
19,975.4820
12/31/2020 - 10/30/2014

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers